Moreover, other authors reported that ciprofloxacin inhibits CYP1A2, with an increase in the blood concentration of substrate drugs (e.g., olanzapine and tizandine) and an increase in ADRs (e.g., QT prolongation and somnolence, respectively) [30,31]. The gene discussed is CYP1A2; the disease is Coma.